Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. Moller CT, Stoer NC, Blindheim A, Berge V, et al. BMC Cancer 2022;22:1301.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moller CT, Stoer NC, Blindheim A, Berge V, et al. Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. BMC Cancer 2022;22:1301.
PMID: 36510166